Trial Profile
Effectiveness and safety of Dimethylfumarate in patients with Palmoplantar Pustulosis – a 24-week, open label, phase II trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2023
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Palmoplantar pustulosis
- Focus Therapeutic Use
- 28 Feb 2023 Status changed from recruiting to discontinued.
- 17 Jan 2018 New trial record